Cyclophosphamide/epirubicin/fluorouracilCongenital malformations (first report with epirubicin) following in utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1346卷 / 1期

关键词：

Breast Cancer; Methotrexate; Cyclophosphamide; Fluorouracil; Epirubicin;

D O I：

10.2165/00128415-201113460-00056

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[31] SpironolactoneAmbiguous genitalia (first report) following in utero exposure: case report
Reactions Weekly, 2011, 1359 (1) : 34 - 34
[32] RosuvastatinTeratogenesis (first report) in an infant following in utero exposure: case report
Reactions Weekly, 2010, 1304 (1) : 32 - 32
[33] SibutramineMastocytomas (first report) in a neonate following in utero exposure: case report
Reactions Weekly, 2006, 1096 (1) : 22 - 23
[34] Epirubicin/dexamethasone interactionCardiotoxicity following in-utero exposure: 2 case reports
Reactions Weekly, 2016, 1594 (1) : 92 - 92
[35] Epirubicin/ifosfamideErythrodysaesthesia (first report with ifosfamide) in an elderly patient: case report
Reactions Weekly, 2008, 1212 (1) : 15 - 15
[36] Epirubicin/ifosfamideNeutropenia: case report
Reactions Weekly, 2015, 1571 (1) : 88 - 88
[37] MetamfetamineCentral nervous system malformations following in utero exposure: case report
Reactions Weekly, 2018, 1711 (1) : 186 - 186
[38] Epirubicin/cyclophosphamidePeriaortitis: case report
Reactions Weekly, 2017, 1680 (1) : 127 - 127
[39] Mycophenolate mofetilCongenital malformations in a neonate following in utero exposure: case report
Reactions Weekly, 2009, 1261 (1) : 21 - 21
[40] Cyclophosphamide/doxorubicin/fluorouracilMicrocephaly following in-utero exposure: case report
Reactions Weekly, 2022, 1897 (1) : 136 - 136

← 1 2 3 4 5 →